The fiscal year 2009 budget for Japan's Ministry of Health, Labor and Welfare's social security including pensions and medical and nursing care increased 14% to 24,830.0 billion yen ($86.9 billion) compared to the year earlier.
Within this: 213.9 billion yen was allocated to disease management, up 5.6%, of which: 22.5 billion yen goes to promoting countermeasures against infectious diseases including a new type of influenza; and 158.7 billion yen for tackling intractable diseases. Projects for hepatitis and the promotion of AIDS prevention will get 20.5 billion yen and 7.5 billion yen, respectively, and 1.1 billion yen was allocated for rheumatic and allergic diseases.
23.7 billion yen and 8.6 billion yen, respectively, were earmarked for cancer prevention and research, and measures against developing diabetes and stroke, along with the promotion of women's health, respectively. The budget for innovative drugs and medical devices was raised by 1.1% to 27.7 billion yen. Within this, 25.1 billion yen has been allocated for research into new advanced technologies including regenerative medicine and personalized therapies, and 400.0 million yen for establishing a world-class infrastructure for clinical research. In addition, 920.0 million yen has been hypothecated for promoting the use of generic drugs.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze